Abstract
A series of novel carboxamides, sulfonamides, ureas, and thioureas derived from 1,2,4-oxadiazol-3-ylmethyl-piperazin-1-yl substituted with pyrazolo[1,5-a]pyrimidine analog were designed and synthesized. The newly synthesized compounds were characterized by 1H NMR, 13C NMR, ESI–MS, and IR and were tested for their in vitro antiproliferative activity by MTT assay. Out of these twenty derivatives, five compounds showed good anticancer activity against HeLa cell line. These are superior with less than 10 µg/cm3 of IC 50 when compared to the marketed anticancer drug paclitaxel with 30 µg/cm3 of IC 50 against Hela cell line.
Graphical abstract
Similar content being viewed by others
References
El-Dean AMK, Elkhawaga AM, Radwan SM, Ahmed MM (2009) Phosphorus Sulfur Silicon Relat Elem 184:2034
Nitulescu GM, Paunescu H, Draghici C, Missir AV, Coman OA, Fulga I (2010) Farmacia 58:190
Vijesh AM, Isloor AM, Shetty P, Sundershan S, Fun HK (2013) Eur J Med Chem 62:410
Aly AA (2006) Phosphorus Sulfur Silicon Relat Elem 181:2395
Gouhar RS, Fathalla OA, Abd El-Karim SS (2013) Pharm Chem 5:225
Rashad AE, Hegab MI, Abdel-Megeid RE, Fathalla N, Abdel-Megeid FME (2009) Eur J Med Chem 44:3285
Prakash O, Bhardwaj V, Kumar R, Tyagi P, Aneja KR (2004) Eur J Med Chem 39:1073
Agarwal N, Raghuwanshi SK, Upadhyay DN, Shukla PK, Ram VJ (2000) Bioorg Med Chem Lett 10:703
Cocco MT, Congiu C, Lilliu V, Onnis V (2006) Bioorg Med Chem 14:366
Botta M, Occhionero F, Nicoletti R, Mastromarino P, Conti C, Magrini M, Saladino R (1999) Bioorg Med Chem 7:1925
Skulnick HI, Ludens JH, Wendling MG, Glenn EM, Rohloff NA, Smith RJ, Wierenga W (1986) J Med Chem 29:1499
Atwal KS, Swanson BN, Unger SE, Floyed DM, Moreland S, Hedberg A, O’Reilly BC (1991) J Med Chem 34:806
Yoo J, Thai KM, Kim DK, Lee JY, Park HJ (2007) Bioorg Med Chem Lett 17:4271
Gonclaves MST, Oliveira-Campos AMF, Rodrigues LM, Proenca MFRP (2009) Synth Commun 39:1186
Shetty NS (2014) Int J Adv Chem Eng Biol Sci 1:80
Ley SV, Thomas AW (2003) Angew Chem Int Ed 42:5400
Nag S, Mishra A, Batra S (2008) Tetrahedron 64:10162
Bruni F, Selleri S, Costanzo A, Guerrini G, Casilli ML, Giusti L (1995) J Heterocycl Chem 32:291
Maeba I, Nishiyama Y, Kanazawa S, Sato A (1995) Heterocycles 41:507
Bellec C, Lhommet G (1995) J Heterocycl Chem 32:1793
Howard AS (1995) Comprehensive heterocyclic chemistry II, vol 8. Pergamon Press, Oxford, p 249
Barret D (1997) Heterocycles 45:1839
Bakavoli M, Bagherzadeh G, Vaseghifar M, Shiri A, Pordel M, Mashreghi M, Pordeli P, Araghi M (2010) Eur J Med Chem 45:647
Curran KJ, Verheijen JC, Kaplan J, Richard DJ, Toral-Barza L, Hollander I, Lucas J, Ayral-Kaloustian S, Yu K, Zask A (2010) Bioorg Med Chem Lett 20:1440
Kim I, Song JH, Park CM, Jeong JW, Kim HR, Ha JR, No Z, Hyun YL, Cho YS, Kang NS, Jeon DJ (2010) Bioorg Med Chem Lett 20:922
Soliman AMM, El-Aleem MA, El-Remaily AA, Sultan AA, Abdel-Ghany H (2014) J Heterocycl Chem 51:1476
Maeda H, Akaike T, Miyamoto Y, Yoshida M (1997) Pyrazolopyrimidine derivatives as antihypertensive agents. EP 0759298A2
Saunders J, Cassidy M, Freedman SB, Harley EA, Iversen LL, Kneen C, MacLeod AM, Merchant KJ, Snow RJ, Baker R (1990) J Med Chem 33:1128
Chen CY, Senanayake CH, Bill TJ, Larsen RD, Verhoeven TR, Reider PJ (1994) J Org Chem 59:3738
Swain CJ, Baker R, Kneen C, Moseley J, Saunders J, Seward EM, Stevenson G, Beer M, Stanton J, Watling K (1991) J Med Chem 34:140
Hosam S (1996) Indian J Chem 35B:980
Ladva K, Patel P, Upadhyay P, Parekh H (1996) Indian J Chem 35B:1062
Sahin G, Palaska E, Ekizoglu M, Ozalp M (2002) Il Farmaco 57:539
Ricardo AW, Neves F, Rajendra MS (2006) Molecules 11:318
Hemming K (2001) J Chem Res 216:209
Andersen KE, Jorgensen AS, Braestrup C (1994) Eur J Med Chem 29:393
Diana GD, Volkots DL, Nitz TJ, Bailey TR, Long MA, Vescio N, Aldous S, Pevear DC, Dutko FJ (1994) J Med Chem 37:2421
Showell GA, Gibbons TL, Kneen CO, MacLeod AM, Merchant KJ, Saunders J, Freedman SB, Patel S, Baker R (1991) J Med Chem 34:1086
Messer WS, Abuh YF, Liu Y, Periyaswamy S, Ngur DO, Edgar MAN, El-Assadi AA, Sbeih Dunbar PG, Roknich S, Rho T, Fang Z, Ojo B, Zhang H, Huzl JJ, Nagy PI (1997) J Med Chem 40:1230
Orlek BS, Blaney FE, Brown F, Clark MSG, Hadley MS, Hatcher J, Riley GJ, Rosenberg HE, Wadsworth HJ, Wyman P (1991) J Med Chem 34:2726
Macor JE, Ordway T, Smith RL, Verhoest PR, Mack RA (1996) J Org Chem 61:3228
Watjen F, Baker R, Engelstoff M, Herbert R, MacLeod A, Knight A, Merchant K, Moseley J, Saunders J (1989) J Med Chem 32:2282
Tully WR, Gardner CR, Gillespie RJ, Westwood R (1991) J Med Chem 34:2060
Clitherow JW, Beswick P, Irving WJ, Scopes DIC, Barnes JC, Clapham J, Brown JD, Evans DJ, Hayes AG (1996) Bioorg Med Chem Lett 6:833
Zhang HZ, Kasibhatla S, Kuemmerle J, Kemnitzer W, Ollis-Mason K, Qiu L, Crogan-Grundy C, Tseng B, Drewe J, Cai SX (2005) J Med Chem 48:5215
Jessan KA, English NM, Wang JY, Maliartchouk S, Archer SP, Qiu L, Brand R, Kuemmerle J, Zhang HZ, Gehlsen K, Drewe J, Tseng B, Xiong-Cai S, Kasibhatla S (2005) Mol Cancer Ther 4:761
Kumar D, Patel G, Johnson EO, Shah K (2009) Bioorg Med Chem Lett 19:2739
Hamlin KE, Weston AW, Fischer FE, Michaels RJ (1949) J Am Chem Soc 71:2731
Regnier G, Canevari R, Douarec JL, Holstorp S, Daussy J (1972) J Med Chem 15:295
Regnier G, Canevari RJ, Laubie MJ, Le Douarec JC (1968) J Med Chem 11:1151
Wang T, Zhang Z, Wallace OB, Deshpande M, Fang H, Yang Z, Zadjura LM, Tweedie DL, Huang S, Zhao F, Ranadive S, Robinson BS, Gong YF, Ricarrdi K, Spicer TP, Deminie C, Rose R, Wang HGH, Blair WS, Shi PY, Lin PF, Colonno RJ, Meanwell NA (2003) J Med Chem 46:4236
Lutz RE, Shearer NH (1947) J Org Chem 12:771
Tangallapally RP, Yendapally R, Lee RE, Lenaerts AJM, Lee RE (2005) J Med Chem 48:8261
Kiritsy JA, Yung DK, Mahony DE (1978) J Med Chem 21:1301
Rajadhyaksha MN, Kolekar SL, Baviskar AY, Panandikar AM (2011) Process for the preparation of a pyrazole derivative. WO2011064798 A1
McCall JM, Kelly RC, Romero DL (2012) Pyrazolopyrimidinone compounds for the inhibition of PASK and their preparation. WO2012149157
Patnaik S, Zheng W, Choi JH, Motabar O, Southall N, Westbroek W, Lea WA, Velayati A, Goldin E, Sidransky E, Leister W, Marugan JJ (2012) J Med Chem 55:5734
Moussa IA, Banister SD, Beinat C, Giboureau N, Reynolds AJ, Kassiou M (2010) J Med Chem 53:6228
Wu YC, Li HJ, Liu L, Wang D, Yang HZ, Chen YJ (2008) J Fluoresc 18:357
Setti EL, Venkatraman S, Palmer JT, Xie X, Cheung H, Yu W, Wesolowski G, Robichaud J (2006) Bioorg Med Chem Lett 16:4296
Ball M, Boyd A, Churchill G, Cuthbert M, Drew M, Fielding M, Ford G, Frodsham L, Golden M, Leslie K, Lyons S, McKeever-Abbas B, Stark A, Tomlin P, Gottschling S, Hajar A, Jiang J, Lo J, Suchozak B (2012) Org Process Res Dev 16:741
Acknowledgments
We would like to thank the Management Team at Anthem Biosciences Pvt. Ltd., Bangalore, India, for their valuable support and allocation of proper resources for the completion of this work. We would also like to thank the Analytical Chemistry Team at the Department of Analytical chemistry, Anthem Biosciences, Bangalore, India, for carrying out all the analytical work described in this study. Also, we would like to thank the Molecular Biology Team at the Maratha Mandal Institute of Technology, Belagavi, Karnataka, India, for conducting the anti-proliferative studies by MTT assay.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ajeesh Kumar, A.K., Nair, K.B., Bodke, Y.D. et al. Design, synthesis, and evaluation of the anticancer properties of a novel series of carboxamides, sulfonamides, ureas, and thioureas derived from 1,2,4-oxadiazol-3-ylmethyl-piperazin-1-yl substituted with pyrazolo[1,5-a]pyrimidine derivatives. Monatsh Chem 147, 2221–2234 (2016). https://doi.org/10.1007/s00706-016-1723-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-016-1723-9